Xbrane Biopharma: Q1 – Approaching readout
Redeye leaves a comment on Xbrane following today’s release of the report for the first quarter. We retain our positive stance as the company approaches the readout of Xplore.
FE
Filip Einarsson
Disclosures and disclaimers